MRA Announces its Tenth Annual Request for Proposals
By Kristen Mueller, Ph.D., MRA Scientific Program Director | 14 August 2017 | News, Science, Treatment
MRA is pleased to announce our 2017/18 Request for Proposals (RFP). As in prior years, MRA seeks high-impact pre-clinical, translational, and early clinical research that has the potential to lead to near-term impact in melanoma prevention, detection, diagnosis, staging, and treatment. This cycle, proposals will be accepted for Team Science Awards, Young Investigator Awards, and Academic-Industry Partnership Awards (for Established Investigators).
MRA encourages applications from a diverse pool of investigators. Investigators need not be specifically trained in melanoma research, however, they should be working in an environment capable of conducting high-quality, high-impact melanoma research.
In an effort to encourage increased parity in the number of grants submitted by female researchers, MRA is proud to offer a Special Opportunity this year for a Young Investigator Award with the goal of attracting and supporting early career female researchers who are conducting cutting-edge melanoma research. All female applicants submitting for Young Investigator Awards in general have the option to also be considered for this award in addition.
This cycle, MRA plans to support at least $9 million in new funding through this RFP with an additional $1 million through the American Cancer Society-MRA joint RFP: Understanding, Preventing and Managing Immunotherapy-Related Adverse Events (irAEs) Associated with Checkpoint Inhibition for Melanoma and Other Cancers, which was announced separately. More details on award types, deadlines, and eligibility criteria can be found at: https://www.curemelanoma.org/research/request-for-proposals/.